This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Galderma Holding Sa. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Fabien Audibert: Innovator in Dermatological Treatments
Introduction
Fabien Audibert is a notable inventor based in Roquette-sur-Siagne, France. He has made significant contributions to the field of dermatology, particularly in the treatment of rosacea. His innovative approach combines established medications to enhance treatment efficacy.
Latest Patents
Audibert holds a patent for the "Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea." This invention focuses on a combination therapy that utilizes a 1% ivermectin cream and a 0.33% brimonidine gel for topical administration. This combination aims to provide effective relief for patients suffering from this skin condition.
Career Highlights
Throughout his career, Fabien Audibert has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Galderma Holding SA and Galderma S.A., where he has contributed to the development of innovative dermatological solutions.
Collaborations
Audibert has collaborated with several professionals in his field, including Philippe Martel and Nabil Kerrouche. These partnerships have likely enriched his research and development efforts, leading to advancements in treatment options.
Conclusion
Fabien Audibert's work exemplifies the impact of innovation in medical treatments, particularly in dermatology. His patent for the combination of ivermectin and brimonidine represents a significant step forward in addressing moderate to severe rosacea.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile